Document is current
Any future updates will be listed below
-
Authors
Wei, Mingyu
Hou, Xiaojie
Zhang, Siyao
Hu, Xianjing
Chen, Xi
Gao, Zhen
Xu, Shuwan
Shi, Zhan
Zhu, Min
Lan, Feng
Cui, Ming
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82070272)
The Beijing Research Ward Excellence Clinical Study Program (BRWEP2024W014090201)
- License Information
-
More Information
Article History
Received: 11 September 2025
Accepted: 5 January 2026
First Online: 16 January 2026
Declarations
:
: The human embryonic stem cell line WAe009-A used in this study was obtained from WiCell Research Institute, Inc., and is registered with the Human Stem Cell Registry (hPSCreg), confirming ethical sourcing and use of human cells. Ethical approval and donor informed consent were obtained, which are available at . Our research adheres to all ethical guidelines and legal regulations, ensuring the use of the WAe009-A cell line meets the highest ethical standards.
: The authors declare no competing interests.
